
OLD Category: immuno-oncology
June 14, 2021 / J Immunother Cancer
Fifteen-year follow-up of relapsed indolent non-Hodgkin lymphoma patients vaccinated with tumor-loaded dendritic cells
June 7, 2021 / Nat Immunol
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent anti-tumor immunity in melanoma
June 3, 2021 / Nat Biomed Eng
T cells armed with the C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours
June 1, 2021 / Transl Lung Cancer Res
Narrative review of immunotherapy in thymic malignancies
May 27, 2021 / Mol Cancer Ther
Oncolytic vaccinia virus gene modification and cytokine expression effects on tumor infection, immune response, and killing
May 17, 2021 / Leukemia
SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
May 14, 2021 / Sci Rep
EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma
May 13, 2021 / J Transl Genet Genom
Omics analyses provide insights to CART cell therapy resistance
May 11, 2021 / J Exp Med